Who is the buyer for this idea?

Clinical operations lead at a CRO or top-20 pharma. Reach them through sponsor dia europe + esmo and patient advocacy group partnerships. Skip broad SEO on day 1 — start where your first 20 customers already hang out.

How would you monetize it?

€2-8k per enrolled patient, €500k-3M per trial. Pricing is the most under-thought step for these buyers, so anchor to the outcome you replace, not the tool you resemble.

EU-CTR unified regulation makes multi-country trials operationally possible. That's the underlying shift — if it fades, so does the wedge.

What tech stack would you use?

Suggested stack: Next.js, Supabase EU, and Weaviate for eligibility matching. You can build the v1 in weeks on this stack; the moat is workflow depth, not framework choice.

Who are the incumbents I'd be competing with?

Study Antidote, Deep 6 AI, and Trialbee — read their 1-star reviews, price ladder, and onboarding. That's where your positioning lives.

Who is the buyer for this idea?

Clinical operations lead at a CRO or top-20 pharma. Reach them through sponsor dia europe + esmo and patient advocacy group partnerships. Skip broad SEO on day 1 — start where your first 20 customers already hang out.

How would you monetize it?

€2-8k per enrolled patient, €500k-3M per trial. Pricing is the most under-thought step for these buyers, so anchor to the outcome you replace, not the tool you resemble.

EU-CTR unified regulation makes multi-country trials operationally possible. That's the underlying shift — if it fades, so does the wedge.

What tech stack would you use?

Suggested stack: Next.js, Supabase EU, and Weaviate for eligibility matching. You can build the v1 in weeks on this stack; the moat is workflow depth, not framework choice.